Sheardown MJ - Search Results

1

Characterization of the metabotropic glutamate receptor in mouse cerebellar granule cells: lack of effect of 2,3-dihydroxy-6-nitro-7-sulphamoylbenzo(F)-quinoxaline (NBQX).

Suzdak PD, Sheardown MJ, Honoré T. Suzdak PD, et al. Among authors: sheardown mj. Eur J Pharmacol. 1993 May 15;245(3):215-20. doi: 10.1016/0922-4106(93)90099-u. Eur J Pharmacol. 1993. PMID: 7687559

2

AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.

Sheardown MJ, Suzdak PD, Nordholm L. Sheardown MJ, et al. Eur J Pharmacol. 1993 Jun 4;236(3):347-53. doi: 10.1016/0014-2999(93)90470-3. Eur J Pharmacol. 1993. PMID: 7689464

3

Effect of the non-NMDA receptor antagonist, 2,3-dihydro-6-nitro-7-sulfamoylbenzo(f)quinoxaline, on local cerebral glucose uptake in the limbic forebrain.

Suzdak PD, Sheardown MJ. Suzdak PD, et al. Among authors: sheardown mj. J Neurochem. 1993 Oct;61(4):1577-80. doi: 10.1111/j.1471-4159.1993.tb13661.x. J Neurochem. 1993. PMID: 8397300

4

Protection against post-ischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil.

Judge ME, Sheardown MJ, Jacobsen P, Honoré T. Judge ME, et al. Among authors: sheardown mj. Neurosci Lett. 1991 Dec 9;133(2):291-4. doi: 10.1016/0304-3940(91)90591-g. Neurosci Lett. 1991. PMID: 1667818

5

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honoré T. Sheardown MJ, et al. Science. 1990 Feb 2;247(4942):571-4. doi: 10.1126/science.2154034. Science. 1990. PMID: 2154034

6

A potent antagonist of the strychnine insensitive glycine receptor has anticonvulsant properties.

Sheardown MJ, Drejer J, Jensen LH, Stidsen CE, Honoré T. Sheardown MJ, et al. Eur J Pharmacol. 1989 Dec 19;174(2-3):197-204. doi: 10.1016/0014-2999(89)90312-9. Eur J Pharmacol. 1989. PMID: 2560979

7

(S)-4-carboxy-3-hydroxyphenylglycine, an antagonist of metabotropic glutamate receptor (mGluR) 1a and an agonist of mGluR2, protects against audiogenic seizures in DBA/2 mice.

Thomsen C, Klitgaard H, Sheardown M, Jackson HC, Eskesen K, Jacobsen P, Treppendahl S, Suzdak PD. Thomsen C, et al. J Neurochem. 1994 Jun;62(6):2492-5. doi: 10.1046/j.1471-4159.1994.62062492.x. J Neurochem. 1994. PMID: 8189254

8

M1 receptor agonist activity is not a requirement for muscarinic antinociception.

Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P. Sheardown MJ, et al. J Pharmacol Exp Ther. 1997 May;281(2):868-75. J Pharmacol Exp Ther. 1997. PMID: 9152396

9

Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic.

Swedberg MD, Sheardown MJ, Sauerberg P, Olesen PH, Suzdak PD, Hansen KT, Bymaster FP, Ward JS, Mitch CH, Calligaro DO, Delapp NW, Shannon HE. Swedberg MD, et al. Among authors: sheardown mj. J Pharmacol Exp Ther. 1997 May;281(2):876-83. J Pharmacol Exp Ther. 1997. PMID: 9152397

10

Protection against ischemic hippocampal CA1 damage in the rat with a new non-NMDA antagonist, NBQX.

Diemer NH, Jørgensen MB, Johansen FF, Sheardown M, Honoré T. Diemer NH, et al. Acta Neurol Scand. 1992 Jul;86(1):45-9. doi: 10.1111/j.1600-0404.1992.tb08052.x. Acta Neurol Scand. 1992. PMID: 1325729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters